• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Model Number GSX0030A
Device Problem Migration (4003)
Patient Problems Tachycardia (2095); Foreign Body Embolism (4439)
Event Date 03/02/2023
Event Type  Injury  
Manufacturer Narrative
The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: device embolization.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported to gore a 30mm gore® cardioform septal occluder was selected to treat a patent foramen ovale for platypnea orthodeoxia.The defect anatomy was aneurysmal and with a stiff amplatz wire across measured 11mm wide in multiple planes.The device was deployed without difficulty, a push pull maneuver was done demonstrating stability.No color was seen crossing the device and the bubble study post release was negative.The following day the patient was experiencing heavy coughing and while walking on the hospital floor her telemetry demonstrated she was getting tachycardic.A chest x-ray was performed and showed the device had embolized right to left and was in a stable position just past the aortic arch.The device was snared successfully and the patient is doing fine post procedure.The device was discarded.The patient to be scheduled for another catheterization procedure.
 
Manufacturer Narrative
The evaluation of the returned occluder showed the following: the overall size and shape of the occluder and its bumper were unremarkable.The distal eyelet was damaged in its returned state.The embolization of the occluder could not be recreated nor confirmed during the evaluation.Thus, the cause of the complaint is unknown and cannot be determined from the evidence available.H6: updated code b18 to b01.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16544802
MDR Text Key311303207
Report Number2017233-2023-03790
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631032
UDI-Public00733132631032
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGSX0030A
Device Catalogue NumberGSX0030A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/02/2023
Initial Date FDA Received03/15/2023
Supplement Dates Manufacturer Received05/11/2023
Supplement Dates FDA Received05/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age66 YR
Patient SexFemale
Patient Weight54 KG
-
-